Morning Market Gainers
March 26, 2015 at 09:42 AM EDT
Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) shares jumped 39.93% to $8.06 on positive Phase 2 liver treatment results. Magal ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|